Source: Annual Congress 2006 - Clinical aspects of obstructive sleep apnoea II
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. P. Laaban, S. Daenen, D. Léger, S. Pascal, E. Staub, A. Mounedji, G. Slama, F. Elgrably (Paris, France). Prevalence and predictive factors of sleep apnea syndrome (SAS) in type 2 diabetic patients with poor diabetic control. Eur Respir J 2006; 28: Suppl. 50, 3776

Member's Comments

No comment yet.

Related content which might interest you: The impact of obstructive sleep apnea (OSA) severity on type 2 diabetes prevalence Source: Sleep and Breathing Conference 2021 Year: 2021 Screening of sleep apnea-hypopnea syndrome in patients with type 2 diabetes Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA Year: 2012 The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011 Prevalence of the sleep apnea syndrome (SAS) in acromegaly population Source: Eur Respir J 2002; 20: Suppl. 38, 576s Year: 2002 High prevalence of obstructive sleep apnea syndrome in a type 1 diabetic adult population: A pilot study Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010 Is IGF-1 a marker of cardio-metabolic risk in sleep apnea syndrome (SAS)? Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea Year: 2016 Microalbuminuria in patients with sleep apnea syndrome (SAS), before and after CPAP use Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Cystatin C as a marker of cardiovascular diseases in patients with obstructive sleep apnea (OSA) with concomitant diabetes mellitus type 2 (DM2) Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Differences in prevalence of metabolic syndrome (MS) between male and female patients with moderate and severe obstructive sleep apnea. The definition is certainly an important factor Source: International Congress 2014 – Sleep disordered breathing 4 Year: 2014 The impact of obstructive sleep apnea syndrome on superoxide dysmutase-1 activity in erythrocytes of high risk for type 2 diabetes (pre-diabetic) males Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea Year: 2011 Prevalence of obstructive sleep apnoea in men with type 2 diabetes Source: Eur Respir J 2005; 26: Suppl. 49, 567s Year: 2005 Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Frequency of metabolic syndrome (MS) in patients with obstructive sleep apnoea (OSA) depends on adopted definition Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Sleep apnea screening questionnaires in patients with type 2 diabetes. Source: International Congress 2018 – Diagnostics including questionnaires Year: 2018 Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Prevalence of residual sleepiness in patients with optimally treated sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 724s Year: 2005 Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Severe sleep apnea, type 2 diabetes and beneficial effects of CPAP on nocturnal glucose control Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Differences in polysomnographic (PSG) parameters between obese and non-obese patients with obstructive sleep apnea (OSA) Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea Year: 2019 Screening for obstructive sleep apnoea (OSA) in patients attending a hypertension clinic with features of the metabolic syndrome Source: Annual Congress 2012 - Snoring and scoring: subjective and objective measures of sleep-disordered breathing Year: 2012